C3 glomerulopathy
At a Glance
C3 glomerulopathy is a rare and chronic kidney disorder caused by a malfunction in the immune system that leads to the buildup of protein deposits in the kidney's filtering units, resulting in inflammation and progressive organ damage.
This ultra-rare condition can affect people of any age, although the subtype known as dense deposit disease is most frequently diagnosed in children and young adults, while C3 glomerulonephritis is commonly found in older adults.
It is a chronic and progressive disease that is treatable and manageable with medication and supportive care, though it currently has no permanent cure and often leads to long-term kidney issues.
The outlook varies by individual, but the condition is serious and frequently progresses to end-stage kidney failure within a decade of diagnosis, often requiring dialysis or a kidney transplant.
How It Affects You
C3 glomerulopathy is a rare kidney disease that occurs when the body's immune system mistakenly attacks the filtering units of the kidneys, leading to inflammation and damage. As the kidneys lose their ability to filter waste and regulate fluids properly, toxic substances build up in the blood and excess fluid accumulates in the body tissues. This process primarily affects the kidneys but has systemic effects, including:
- Swelling (edema) in the legs, ankles, hands, and face due to fluid retention.
- High blood pressure caused by the kidneys' inability to regulate fluid balance.
- Fatigue and weakness resulting from the buildup of waste products and loss of protein in the urine.
Causes and Risk Factors
Underlying Biological Mechanisms
C3 glomerulopathy is caused by a specific malfunction in a part of the immune system called the complement system. Normally, this system helps destroy bacteria and viruses. In people with this condition, the alternative pathway of the complement system becomes overactive and does not turn off when it should. This uncontrolled activity leads to the breakdown of a protein called C3, which then gets trapped in the glomeruli (the tiny filtering units of the kidney). These deposits trigger inflammation and damage the kidney tissue, preventing it from filtering blood properly.
Genetic and Acquired Factors
The dysregulation of the complement system can stem from genetic mutations or acquired factors. Some individuals are born with changes in genes that regulate the immune system, such as the C3, CFH, or CFI genes. In other cases, the body produces autoantibodies—proteins that mistakenly attack the body's own enzymes—such as the C3 nephritic factor (C3NeF). These autoantibodies stabilize certain immune proteins, keeping the system in a constant state of activation. It is possible to have both genetic predispositions and acquired autoantibodies.
Triggers and Risk Factors
While the primary cause is internal, certain external events can trigger the disease or cause flare-ups. Infections, particularly upper respiratory infections like strep throat, often precede the onset of visible symptoms or cause the condition to worsen. There are no specific lifestyle risk factors like diet or smoking that directly cause the disease, as it is primarily driven by biological and genetic drivers. It is not contagious and cannot be passed from person to person like a cold.
Prevention
Because C3 glomerulopathy is caused by genetic factors or autoimmune dysfunction, there is currently no known way to prevent the condition from developing (primary prevention). Strategies focus on preventing further kidney damage once the disease is identified. This includes strictly managing blood pressure, treating infections promptly to avoid immune system spikes, and avoiding medications that might harm the kidneys (nephrotoxins). Regular monitoring is essential to catch progression early.
Diagnosis, Signs, and Symptoms
Signs and Symptoms
The symptoms of C3 glomerulopathy result from the kidney's inability to filter blood and regulate fluid. The most common sign is visible blood in the urine (hematuria), which may look pink, red, or dark like tea. Urine may also appear foamy or bubbly due to high levels of protein leaking from the kidneys (proteinuria). As kidney function declines, fluid builds up in the body, causing swelling (edema) in the legs, ankles, feet, hands, and around the eyes. Patients often experience high blood pressure and persistent fatigue. In the subtype known as dense deposit disease (DDD), patients may also develop fatty deposits in the retina of the eye (drusen) which can affect vision, or rare changes in body fat distribution (lipodystrophy).
Diagnosing the Condition
Diagnosing C3 glomerulopathy requires specialized testing because its symptoms mimic other kidney diseases. Doctors start with urinalysis to check for red blood cells and protein, and blood tests to measure creatinine (waste product) and complement protein levels (specifically low C3 levels). The definitive diagnosis is made through a kidney biopsy, where a small sample of tissue is removed and examined under a microscope. Pathologists use a technique called immunofluorescence to see if C3 protein deposits are present without significant amounts of other immune proteins (immunoglobulins). Genetic testing and tests for autoantibodies (like C3 nephritic factor) are also used to identify the specific cause.
Differential Diagnosis
Clinicians must distinguish this condition from other forms of glomerulonephritis, particularly infection-related glomerulonephritis (which usually resolves on its own) and immune-complex mediated diseases like lupus nephritis or IgA nephropathy. The specific pattern of C3 deposits found in the biopsy is the key factor that separates C3 glomerulopathy from these other conditions.
Treatment and Management
Medications and Targeted Therapies
Treatment aims to stop the overactive immune system and control symptoms to prolong kidney life. Standard management includes blood pressure medications like ACE inhibitors or ARBs, which also help reduce protein loss in the urine. Immunosuppressive drugs, such as corticosteroids and mycophenolate mofetil, are often prescribed to dampen the immune response, though their effectiveness varies from person to person. More recently, targeted therapies known as complement inhibitors (such as pegcetacoplan or eculizumab) are being used or investigated to directly block the specific immune pathway responsible for the disease, offering new hope for stabilizing kidney function.
Procedures and Advanced Care
If the disease progresses to kidney failure, renal replacement therapy becomes necessary. This involves dialysis (mechanically filtering the blood) or a kidney transplant. While transplantation can restore function, C3 glomerulopathy has a high rate of recurrence in the new kidney. Therefore, doctors carefully monitor transplant recipients and may continue immune-suppressing treatments to protect the new organ.
Lifestyle and Self-Care
Patients are encouraged to adopt a kidney-friendly diet, often restricting sodium (salt) to help control blood pressure and swelling. Depending on lab results, protein, potassium, and phosphorus intake may also need to be managed. quitting smoking and maintaining a healthy weight are important for overall kidney health. Regular exercise is beneficial but should be balanced with rest to manage fatigue.
When to Seek Medical Care
Patients should contact their healthcare provider if they notice sudden worsening of swelling in the legs or face, a significant decrease in urine output, or urine that turns very dark or red. Uncontrolled high blood pressure, severe headaches, or difficulty breathing (which may indicate fluid in the lungs) require immediate medical attention. Routine follow-up is critical to monitor kidney function labs and adjust medications.
Severity and Prognosis
Seriousness and Disease Course
C3 glomerulopathy is a serious condition characterized by a variable but generally progressive course. Some patients may experience a slow decline in kidney function over many years, while others face a rapid deterioration. It is rare for the condition to go into spontaneous remission without treatment. The disease is classified as chronic, meaning it persists for a lifetime, although symptoms can fluctuate.
Complications
The most significant complication is the progression to end-stage renal disease (ESRD), where the kidneys can no longer support the body's needs. This occurs in approximately 50% of adult patients within 10 years of diagnosis. Other complications include severe hypertension (high blood pressure), which increases the risk of heart disease and stroke. Children with the disease may experience growth delays due to chronic kidney insufficiency. In rare cases involving dense deposit disease, vision problems can develop due to retinal deposits.
Prognosis and Factors Influencing Outcomes
Prognosis depends heavily on how much kidney damage has occurred before diagnosis and how well the patient responds to treatment. Factors associated with a poorer outlook include high levels of protein in the urine, older age at onset, and biopsy results showing extensive scarring. While the condition significantly impacts health, mortality is generally related to the complications of kidney failure rather than the disease itself. Modern treatments, particularly complement inhibitors, are improving the ability to delay progression, but the risk of recurrence after kidney transplantation remains a major challenge for long-term management.
Impact on Daily Life
Managing Daily Activities
Living with C3 glomerulopathy often requires adjusting daily routines to accommodate lower energy levels. Fatigue is a common complaint, so patients may need to pace themselves at work or school and prioritize rest. Dietary restrictions, such as low-sodium or renal diets, can make social eating and meal planning more complex. Patients on dialysis must schedule their lives around treatment sessions, which can limit travel and flexibility.
Mental and Emotional Health
The chronic nature of the disease and the uncertainty of progression can lead to anxiety and depression. Coping with a rare disease can feel isolating, as few people understand the condition. Connecting with patient support groups or a mental health professional can provide essential emotional support. It is important to communicate openly with family and employers about limitations and needs.
Questions to Ask Your Healthcare Provider
Patients can better manage their care by asking specific questions during appointments:
- What is my current stage of kidney function (GFR) and has it changed since my last visit?
- Am I a candidate for any new targeted therapies or clinical trials?
- What specific dietary changes should I make based on my current lab results?
- How will we monitor for recurrence if I undergo a kidney transplant?
- What signs of infection should I look out for, and how should I treat them?
- Are there genetic implications for my family members?
Common Questions and Answers
Q: Is C3 glomerulopathy genetic?
A: It can be. While many cases are sporadic (happening by chance), genetic mutations in complement regulatory genes are found in some patients. Genetic testing can help determine if there is a hereditary component.
Q: Is there a cure for this condition?
A: Currently, there is no cure that eliminates the disease entirely. Treatment focuses on managing symptoms, slowing the damage to the kidneys, and preventing kidney failure.
Q: Is C3 glomerulopathy contagious?
A: No, it is an autoimmune kidney disorder. You cannot catch it from someone else, nor can you spread it to others.
Q: What is the difference between C3 Glomerulonephritis (C3GN) and Dense Deposit Disease (DDD)?
A: Both are types of C3 glomerulopathy. They are distinguished by how the deposits look under an electron microscope. DDD has dense, ribbon-like deposits in the kidney membranes, while C3GN has lighter, more scattered deposits. DDD is more common in children, while C3GN is often seen in older adults.
Q: Can I still lead a normal life with this condition?
A: Many patients lead active, fulfilling lives, though they may need to manage medications, diet, and doctor visits closely. If kidney failure occurs, treatments like dialysis or transplant allow patients to continue living, though with significant lifestyle adjustments.